Next Article in Journal
Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future
Next Article in Special Issue
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
Previous Article in Journal
Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias
 
 
Review

Article Versions Notes

Cancers 2022, 14(6), 1403; https://doi.org/10.3390/cancers14061403
Action Date Notes Link
article xml file uploaded 9 March 2022 16:12 CET Original file -
article xml uploaded. 9 March 2022 16:12 CET Update https://www.mdpi.com/2072-6694/14/6/1403/xml
article pdf uploaded. 9 March 2022 16:12 CET Version of Record https://www.mdpi.com/2072-6694/14/6/1403/pdf
article html file updated 9 March 2022 16:13 CET Original file -
article html file updated 1 August 2022 04:54 CEST Update https://www.mdpi.com/2072-6694/14/6/1403/html
Back to TopTop